Company
United StatesCatalyst Pharmaceuticals, Inc., Coral Gables, FL – FDA Inspections
Inspection records and compliance data for Catalyst Pharmaceuticals, Inc. in Coral Gables, Florida. 2 FDA inspections on record, 1 Form 483, last inspected June 22, 2023.
Company Profile
This profile covers Catalyst Pharmaceuticals, Inc. based in Coral Gables, Florida, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected July 27, 2018. Last inspected June 22, 2023.
Most cited issue areas
- General responsibilities of sponsors1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 22, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1209618 |
| July 27, 2018 | VAI | Human Drugs · Bioresearch Monitoring | 1061547 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Catalyst Pharmaceuticals, Inc.
FEI Number
3010862019
Address
355 Alhambra Cir Ste 801, Coral Gables, Florida 33134, United States
Country
United States
ID: b49a7d5c-19ad-4b34-acbc-3fc628d1825a